2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Inflammation

2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole has been researched along with Inflammation* in 4 studies

Reviews

1 review(s) available for 2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Inflammation

ArticleYear
Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging.
    Dementia and geriatric cognitive disorders, 2014, Volume: 37, Issue:1-2

    Neuroinflammation plays a crucial role in the pathogenesis of Alzheimer's disease (AD). Its relationship with underlying β amyloid deposition remains unclear. In vivo visualization of microglial activation has become possible with the development of molecular imaging ligands when used with positron emission tomography (PET). The translocator protein (TSPO) is upregulated during neuroinflammation. Consequently, targeting TSPO with radiolabeled ligands for PET is an attractive biomarker for neuroinflammation.. A review of the research literature on PET imaging which studied in vivo neuroinflammation in AD subjects and its relationship with amyloid load was performed, including papers published between 2001 and 2012.. Six studies were included using either [(11)C]PK-11195 or another non-TSPO radioligand that binds to the monoaminooxidase B. All the studies evaluated amyloid load with [(11)C]PIB. Microglial activation and astrocytosis are potentially early phenomena in AD. However, the individual levels of amyloid deposition and microglial activation were not correlated.. Noninvasive in vivo molecular imaging to visualize neuroinflammation in AD may contribute to our understanding of the kinetics of neuroinflammation and its relationship to the hallmarks of the disease. Both are important for the development of future therapeutic modalities and for quantifying the efficacy of future disease-modifying treatments.

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Humans; Inflammation; Isoquinolines; Mitochondrial ADP, ATP Translocases; Molecular Imaging; Monoamine Oxidase; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles

2014

Other Studies

3 other study(ies) available for 2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Inflammation

ArticleYear
Association of Early β-Amyloid Accumulation and Neuroinflammation Measured With [
    Neurology, 2021, 03-23, Volume: 96, Issue:12

    To examine whether early β-amyloid (Aβ) accumulation and metabolic risk factors are associated with neuroinflammation in elderly individuals without dementia.. We examined 54 volunteers (mean age 70.0 years, 56% women, 51%. Among the whole study group, no significant association was found between [. While there was no association between amyloid and neuroinflammation in the overall study group, neuroinflammation was associated with amyloid among the subgroup at early stages of amyloid pathology.

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Brain; Female; Finland; Humans; Inflammation; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Receptors, GABA; Thiazoles

2021
Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:3

    Neuroinflammation has been associated with various neurologic diseases, including Alzheimer disease (AD). In AD, the translocator protein 18 kDa (TSPO) is overexpressed in the activated microglia that surround the β-amyloid plaques. In the current longitudinal study using a mouse model of AD, we evaluated the association between β-amyloid deposition and neuroinflammation in AD.

    Topics: Alzheimer Disease; Aniline Compounds; Animals; Benzothiazoles; Brain; Carbazoles; Disease Models, Animal; Female; Inflammation; Longitudinal Studies; Mice; Positron-Emission Tomography; Thiazoles

2018
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, Oct-10, Volume: 27, Issue:41

    We provide the first evidence for the capability of a high-resolution positron emission tomographic (PET) imaging system in quantitatively mapping amyloid accumulation in living amyloid precursor protein transgenic (Tg) mice. After the intravenous administration of N-[11C]methyl-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (or [11C]PIB for "Pittsburgh Compound-B") with high-specific radioactivity, the Tg mice exhibited high-level retention of radioactivity in amyloid-rich regions. PET investigation for Tg mice over an extended range of ages, including longitudinal assessments, demonstrated age-dependent increase in radioligand binding consistent with progressive amyloid accumulation. Reduction in amyloid levels in the hippocampus of Tg mice was also successfully monitored by multiple PET scans along the time course of anti-amyloid treatment using an antibody against amyloid beta peptide (Abeta). Moreover, PET scans with [18F]fluoroethyl-DAA1106, a radiotracer for activated glia, were conducted for these individuals parallel to amyloid imaging, revealing treatment-induced neuroinflammatory responses, the magnitude of which intimately correlated with the levels of pre-existing amyloid estimated by [11C]PIB. It is also noteworthy that the localization and abundance of [11C]PIB autoradiographic signals were closely associated with those of N-terminally truncated and modified Abeta, AbetaN3-pyroglutamate, in Alzheimer's disease (AD) and Tg mouse brains, implying that the detectability of amyloid by [11C]PIB positron emission tomography is dependent on the accumulation of specific Abeta subtypes. Our results support the usefulness of the small animal-dedicated PET system in conjunction with high-specific radioactivity probes and appropriate Tg models not only for clarifying the mechanistic properties of amyloidogenesis in mouse models but also for preclinical tests of emerging diagnostic and therapeutic approaches to AD.

    Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Antibodies; Disease Models, Animal; Female; Inflammation; Longitudinal Studies; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurofibrillary Tangles; Positron-Emission Tomography; Thiazoles

2007